Dr. Carmen J. Laboy, D.M.D. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: Urb. La Vega Calle Principal Num. 46, Villalba, PR 00766 Phone: 787-847-6593 Fax: 787-847-8272 |
Migdalia Colon-zayas, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: Road 149 Km. 58 Hm. 6, Tierra Santa, Villalba, PR 00766 Phone: 787-847-1325 Fax: 787-847-2672 |
Dr. Jose Rivera Ayala, DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 23 Calle Barcelo, Villalba, PR 00766 Phone: 787-847-4410 Fax: 787-847-2946 |
Dr. Jose Luis Torres Sr., DMD Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 18 Calle Munoz Rivera, Villalba, PR 00766 Phone: 787-847-2955 Fax: 787-847-2955 |
Efrain Vargas, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: Barcelo St, No 46, Villalba, PR 00766 Phone: 787-847-2770 |
News Archive
A new study released today by VitalSmarts found that five threats to workers' safety are commonly left undiscussed and lead to avoidable injury or fatalities.
Boston Scientific, the second-biggest cardiac-device maker, will pay $150 million when the deal closes and another $150 million if Cameron's technology called the S-ICD System wins U.S. Food and Drug Administration approval, the Natick, Massachusetts-based company said in a statement yesterday.
Since 1994, hospitals achieving Magnet status by the American Nurses Credentialing Center have boasted of nursing excellence, quality care, and innovations in nursing practice above that provided by hospitals not attaining the recognition.
Nightingale Informatix Corporation, an application service provider of electronic medical record (EMR) software and related services today announces that it has signed a five-year agreement with the AIM Health Group to provide AIM's family practice, walk-in and pain management clinics with Nightingale On Demand, the Company's enterprise EMR and practice management solution.
Investigators from the International Center for Biomedicine and the University of Chile, in collaboration with the Center for Bioinformatics of the Universidad de Talca, have discovered that two drugs, the benzimidazole derivatives lanzoprazole and astemizole, may be suitable for use as PET (positron emission tomography) radiotracers and enable imaging for the early detection of Alzheimer's Disease. The study is published in the current issue of the Journal of Alzheimer's Disease.
› Verified 6 days ago